India to Philippines: Erythromycin Export Trade Route

The India to Philippines Erythromycin corridor is one of India's established pharmaceutical export routes, with 46 shipments documented worth a combined $11.4M USD. The route is dominated by BDH INDUSTRIES LIMITED, which alone accounts for roughly 49% of all export value, reflecting the consolidated nature of India's erythromycin manufacturing sector.

Across 15 active suppliers, the average shipment value stands at $247.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during April–June, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 23.8%, placing it at rank #14 among India's top erythromycin export destinations globally.

On the import side, key buyers of Indian erythromycin in Philippines include NELPA LIFESCIENCES INC, PHILGEN PHARMACEUTICALS INC, GREEN CORE PHARMA INC.NO.460,RM and 10 others. NELPA LIFESCIENCES INC is the single largest importer with 9 shipments valued at $10.6M USD.

India's erythromycin exports to Philippines are driven primarily by a handful of large-scale manufacturers. BDH INDUSTRIES LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 15 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BDH INDUSTRIES LIMITED, VINS INTERNATIONAL PRIVATE LIMITED, CENTURION LABORATORIES PRIVATE LIMITED — together account for 94% of total trade value on this route. The average shipment value of $247.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical products harmless medicine, erythcin (erythromycin stearate tablets usp 500 mg) (pack 10 x 10 t) and erythromycin as stearate 500 mg tablet tromxene, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NELPA LIFESCIENCES INC is the largest importer with 9 shipments worth $10.6M USD — representing 93% of all erythromycin imports from India on this route. A total of 13 buyers are active on this corridor.